Skip to main content

Table 1 Patients’ characteristics

From: Gallbladder function predicts subsequent biliary complications in patients with common bile duct stones after endoscopic treatment?

Parameter

Number (%)

Gender (male)

76 (64.4%)

Age (mean±SD)

63.6±17.5 years

Smoking

31 (26.3%)

Alcohol drinking

18 (15.3%)

Concomitant disease

 Chronic lung diseases

7 (5.9%)

 Cerebrovascular diseases

7 (5.9%)

 Cardiovascular diseases

53 (44.9%)

 Renal failure

7 (5.9%)

 Cancer diseases

12 (10.2%)

 Liver disease

12 (10.2%)

 Diabetes mellitus

25 (21.2%)

Juxtapapillary diverticulum

45 (38.1%)

Gallbladder stones

86 (72.9%)

Biliary pancreatitis

24 (20.3%)

CBD diameter (mean±SD)

1.2±0.4 cm

Number of CBD stones (no/single /multiple)

23/59/36 (20/50/30)

Largest CBD stones size (mean±SD)a

0.9±0.4 cm

Endoscopic procedures (EST/EPBD)

5/113 (4/96)

Mean balloon diameter for EPBD (mean±SD)

1.1±0.2 cm

Mechanical lithotripsy

12 (10.2%)

Sessions for bile duct clearance(> 1 session)

8 (6.8%)

Stone colora

 Cholesterol and black pigment stones

44 (46%)

 Brown pigment stones

51 (54%)

Mean ERCP procedure time (mean±SD)

49.2±22.2 min

Postprocedural complications

4 (3.4%)

Follow up time (median, range) months

33 (15 to 56)

Recurrent biliary complications

23 (19.5%)

Spontaneous passage of gallstones

15 (15/86 = 17.4%)

Death during follow up

6 (5.1%)

  1. CBD: common bile duct, EST: endoscopic sphincterotomy, EPBD: endoscopic papillary balloon dilation
  2. a23 patients with stone pass-out were not included